Navigation Links
Maxygen Licenses Dengue Vaccine Technology to sanofi pasteur
Date:12/4/2007

REDWOOD CITY, Calif., Dec. 4 /PRNewswire-FirstCall/ -- Maxygen, Inc. (Nasdaq: MAXY), a biotechnology company focused on the development of improved protein drugs, announced today the license of its proprietary dengue virus antigen technology to sanofi pasteur, the vaccines division of the sanofi-aventis Group.

Under the terms of the agreement, Maxygen will transfer to sanofi pasteur a portfolio of preclinical dengue antigens for development and worldwide commercialization of a second generation vaccine. In addition to royalties, total event payments to Maxygen, including an upfront fee, could total $24.5 million.

The dengue virus is a mosquito-borne pathogen that infects over 50 million people each year, causing 500,000 hospitalizations for Dengue Hemorrhagic Fever/ Dengue Shock Syndrome, according to The World Health Organization (WHO). Without proper treatment, Dengue Shock Syndrome can be fatal.(1) WHO estimates that more than 20,000 people worldwide, mainly children, die each year from infection with the virus. While the majority of deaths occur in tropical and subtropical regions, the virus is spreading to new regions of the world, including Northern Australia, the Middle East, Central America, and the southern part of the United States. WHO estimates that 40 percent of the world's population is currently at risk of dengue infection.(2)

To date, efforts to develop a dengue vaccine have been challenged by the existence of four different serotypes of dengue virus, all of which are responsible for the severe form of the disease called Dengue Hemorrhagic Fever. To overcome this challenge, Maxygen used its proprietary MolecularBreeding(TM) directed molecular evolution platform. Segments of DNA fro
'/>"/>

SOURCE Maxygen, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Maxygen Announces Hold on MAXY-alpha Development Program
2. Maxygen Third Quarter 2007 Financial Results Conference Call Notice
3. Maxygen Announces Upcoming Webcasts at Investor Conferences
4. Maxygen Reports Third Quarter 2007 Financial Results
5. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
6. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production
7. Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan
8. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
9. Southern Research Institute Licenses Anti-Cancer Drug Compound to Virium Pharmaceuticals
10. Protherics Licenses its CoVaccine HT Adjuvant to Nobilon for Influenza Vaccine Indications
11. HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Shimadzu Scientific Instruments has released the DSES-1000 long-travel ... for measuring displacement in rubber and other soft ... distance, the DSES-1000 can measure elongations up to ... mm. In addition, it achieves +/- 0.2 percent ... +/- 100 µm below 50-mm stroke. , The ...
(Date:9/30/2014)... Md. , Sept. 30, 2014  RegeneRx ... today announced that it has received a Canadian ... by Actin-Sequestering Peptides.  This patent includes claims using ... numerous other actin-sequestering peptides for these purposes.  The ... About RegeneRx Biopharmaceuticals, Inc. ( www.regenerx.com ) ...
(Date:9/30/2014)... 30, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... Office (USPTO) issued U.S. Patent No. 8,816,083 to ... Benzoic Acid Derivatives and Heteroaryl Carboxylic Acid Conjugates ... Thereof." The patent, which extends through ...
(Date:9/30/2014)... 30, 2014 The custom stainless steel ... Product Show 2014. The Boston Area Chapter of ISPE ... annual, day-long event for Wed., Oct. 1 at Gillette ... be the largest in ISPE Boston’s long history, with ... 3,000 attendees expected. , HOLLOWAY AMERICA President David ...
Breaking Biology Technology:Shimadzu’s New Long-Travel Extensometer Increases Precision for Soft Material Testing 2RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2KemPharm, Inc. Receives Patent from the USPTO for Novel Prodrug of Hydromorphone, KP511 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3
... The " Acute Myeloid Leukemia Therapeutics ... analyzes and studies the major market drivers, restraints, ... and Japan. Browse market data ... Myeloid Leukemia Therapeutics Market in G8 Countries (2010 - ...
... ALTO, Calif., Dec. 19, 2011 Varian Medical Systems (NYSE: ... results for the first quarter of fiscal year 2012 following ... The news release will be followed by a teleconference available ... release and a link to the conference call webcast will ...
... electrons move past atoms in a solid, their charge distorts ... wave in the lattice affects the electrons motion, in analogy ... riding it. This interaction results in a thermoelectric effect that ... be known as phonon-drag, because it can be quantified from ...
Cached Biology Technology:MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020 2MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020 3Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call 2A 50-year quest to isolate the thermoelectric effect is now over: Magnon drag unveiled 2
(Date:9/30/2014)... think of nature as something that we enjoy when we ... Or do we think of ourselves as a part of ... what about a house? , The answers to these ... our actions, our speech and in cultural artifacts. , A ... Washington, the American Indian Center of Chicago and the Menominee ...
(Date:9/30/2014)... 30, 2014--Sea monkeys have captured the popular attention of ... observable life cycle -- sold as dehydrated eggs, these ... little more than a tank of salt water. ... Like other zooplankton, brine shrimp vertically migrate in large ... to the surface at night and retreating deeper during ...
(Date:9/30/2014)... and engineers, led by Clemson University associate professor ... grant from the U.S. Department of Energy,s Experimental ... direct positive impact on South Carolina in the ... contaminants. , "Understanding the scientific and engineering needs ... of nuclear technologies is imperative if South Carolina ...
Breaking Biology News(10 mins):The cultural side of science communication 2Laser-guided sea monkeys show how zooplankton migrations may affect global ocean currents 2Researchers get $5.25 million to advance nuclear technologies in South Carolina 2
... of 3-D printing a major body organ like a kidney ... national hub for human organs partly due to regenerative medicine ... seem to be coming faster than the public can understand ... legal and moral considerations. To spark the national ...
... in the African rainforests has halved the number of primates. ... in the number of primates causes a reduction in the ... a reduction in the numbers of important fruit trees and ... research from Lund University in Sweden. The destruction of ...
... extraction from soybean seeds. It is rich in protein, which ... the seeds and dependent on the line, and can also ... The study looked at the role soybeans could have ... lines which were high in oleic acid and protein, the ...
Cached Biology News:'After the Genome' tackles tough questions about medicine, miracles and morality 2'After the Genome' tackles tough questions about medicine, miracles and morality 3Hunting for meat impacts on rainforest 2
Application: for RNase- decontamination , Registered Trademark of Ambion. ,Special grade: for molecular biology Density: 1.00 g/mL (20 C) Suitab tst: RNase decontamination in accordance...
... Application: A cleaning agent for ... surfaces, countertops, and pipettors. ... eliminating RNase contamination from microcentrifuge ... reactions. ,RNase Zap (R) ...
Mol wt: average mol wt12,360.96 Da by calculation...
... is part of a series of media originally ... Weiss et al. for the large scale propagation ... medium is primarily used for the growth and ... the propagation of viruses in these cell lines. ...
Biology Products: